Impact of Time from Referral to Treatment on Outcomes and Cost of Therapy for Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma: An Intention to Treat Analysis

被引:0
|
作者
Patel, Vivek [1 ]
Baker, Katherine [1 ]
Fishman, Danielle [1 ]
Lessans, Spencer [1 ]
Morris, Trent [1 ]
Dholaria, Bhagirathbhai [1 ]
Jayani, Reena [1 ]
Kassim, Adetola A. [1 ]
Kim, Tae Kon [1 ]
Morgan, David [1 ]
Oluwole, Olalekan O. [1 ]
Savani, Bipin N. [1 ]
Sengsayadeth, Salyka M. [1 ]
Bhaskar, Shakthi [1 ]
机构
[1] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN USA
关键词
D O I
10.1182/blood-2023-189084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Bilateral Cytomegalovirus Retinitis After Chimeric Antigen Receptor T-cell Therapy for B-cell Lymphoma
    Meller, Leo
    Jagadeesh, Vasan
    Wilson, Katherine
    Oca, Michael C.
    Sestak, Timothy
    Scott, Nathan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [22] Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Lin, Richard J.
    Lobaugh, Stephanie M.
    Pennisi, Martina
    Chan, Hei Ton
    Batlevi, Yakup
    Ruiz, Josel D.
    Elko, Theresa A.
    Maloy, Molly A.
    Batlevi, Connie L.
    Dahi, Parastoo B.
    Hamlin, Paul A.
    Giralt, Sergio A.
    Hamlin, Paul A.
    Mead, Elena
    Noy, Ariela
    Palomba, M. Lia
    Santomasso, Bianca D.
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    Korc-Grodzicki, Beatriz
    Kim, Soo Jung
    Silverberg, Mari Lynne
    Brooklyn, Chelsea A.
    Devlin, Sean M.
    Perales, Miguel-Angel
    HAEMATOLOGICA, 2021, 106 (01) : 255 - 258
  • [23] CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN ADULT PATIENTS WITH B-CELL LYMPHOPROLIFERATIVE DISEASES
    Gavrilina, O. A.
    Galstyan, G. M.
    Shchekina, A. E.
    Kotova, E. S.
    Maschan, M. A.
    Troitskaya, V. V.
    Koroleva, D. A.
    Zvonkov, E. E.
    Fidarova, Z. T.
    Vasilyeva, V. A.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (01): : 8 - 28
  • [24] Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
    Jallouk, Andrew P.
    Kui, Naishu
    Sun, Ryan
    Westin, Jason R.
    Steiner, Raphael E.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Fayad, Luis E.
    Al Zaki, Ajlan
    Hawkins, Misha
    Adkins, Sherry
    Noorani, Mansoor
    Das, Kaberi
    Henderson, Jared
    Shpall, Elizabeth J.
    Kebriaei, Partow
    Ramdial, Jeremy
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Ahmed, Sairah
    Strati, Paolo
    HAEMATOLOGICA, 2024, 109 (05) : 1460 - 1468
  • [25] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Zixun Yin
    Ya Zhang
    Xin Wang
    Biomarker Research, 9
  • [26] Efficacy of Chimeric Antigen Receptor T-Cell Therapy Is Not Impaired By Previous Bispecific Antibody Treatment in Patients with Large B-Cell Lymphoma
    Iacoboni, Gloria
    Crochet, Gilles
    Couturier, Audrey
    Bachy, Emmanuel
    Iraola, Josu
    Gastinne, Thomas
    Herbaux, Charles
    Fradon, Tom
    Kwon, Mi
    Gounot, Romain
    Martinez-Cibrian, Nuria
    Castilla-Llorente, Cristina
    Guerreiro, Manuel
    Sarkozy, Clementine
    Aspa-Cilleruelo, Jose
    Camus, Vincent
    Guidez, Stephanie
    Chauchet, Adrien
    Deconinck, Eric
    Bouabdallah, Krimo
    Barba, Pere
    Houot, Roch
    Morschhauser, Franck
    BLOOD, 2023, 142
  • [27] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
  • [28] Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
    Manzar, Gohar S.
    Pinnix, Chelsea C.
    Dudzinski, Stephanie O.
    Marqueen, Kathryn E.
    Cha, Elaine E.
    Nasr, Lewis F.
    Yoder, Alison K.
    Rooney, Michael K.
    Strati, Paolo
    Ahmed, Sairah
    Nze, Chijioke
    Nair, Ranjit
    Fayad, Luis E.
    Wang, Michael
    Nastoupil, Loretta J.
    Westin, Jason R.
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Gunther, Jillian R.
    Dabaja, Bouthaina S.
    Wu, Susan Y.
    Fang, Penny Q.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [29] Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis
    Kelkar, Amar H.
    Cliff, Edward R. Scheffer
    Jacobson, Caron A.
    Abel, Gregory A.
    Dijk, Stijntje W.
    Krijkamp, Eline M.
    Redd, Robert
    Zurko, Joanna C.
    Hamadani, Mehdi
    Hunink, M. G. Myriam
    Cutler, Corey
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1625 - 1637
  • [30] Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
    Trando, Aaron
    Ter-Zakarian, Anna
    Yeung, Phillip
    Goodman, Aaron M.
    Hamdan, Ayad
    Hurley, Michael
    Jeong, Ah-Reum
    Tzachanis, Dimitrios
    CANCERS, 2023, 15 (18)